Balchem Corporation(NASDAQ:BCPC) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 5, 2016. Company reported revenue of $138.79M. Analysts estimated a revenue of $151.72M. Earnings per share were $0.66. Analysts had estimated an EPS of $0.65.
Balchem Corporation (BCPC) shares turned negative on Wednesdays trading session with the shares closing down -0.02 points or -0.03% at a volume of 92,537. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $67.59. The peak price level was also seen at $67.59 while the days lowest was $66.46. Finally the shares closed at $66.86. The 52-week high of the shares is $70.91 while the 52-week low is $53.109. According to the latest information available, the market cap of the company is $2,115 M.
Several Insider Transactions has been reported to the SEC. On Jul 14, 2016, Dino A Rossi (director) sold 16,600 shares at $62.29 per share price.Also, On May 17, 2016, Matthew David Houston (General Counsel/Secretary) sold 5,000 shares at $62.73 per share price.On Nov 12, 2015, John Y Televantos (director) sold 6,435 shares at $64.41 per share price, according to the Form-4 filing with the securities and exchange commission.
Balchem Corporation (Balchem) is engaged in the development manufacture distribution and marketing of specialty performance ingredients and products for the food nutritional feed pharmaceutical and medical sterilization industries. The Company operates in three segments: Specialty Products SensoryEffects and Animal Nutrition & Health (ANH). The Company sells its products through its own sales force independent distributors and sales agents. The Specialty Products segment offers Ethylene oxide canisters and propylene oxide. The SensoryEffects segment provides creamer systems dairy replacers powdered fats nutritional beverage bases beverages juice and dairy bases chocolate systems ice cream bases and variegates ready-to-eat cereals grain-based snacks and cereal-based ingredients. ANH segment provides basic choline chloride and microencapsulation and chelation technologies-based nutritional products.